Phone: (212) 746-5788
Fax: (212) 746-0975
March 10, 2010 5:59 pm
Recent Results of High-dose Proleukin® for Metastatic Renal Cell Carcinoma ... - Cancer Consultants
Google News - renal cell carcinoma
Recent Results of High-dose Proleukin® for Metastatic Renal Cell Carcinoma ... Cancer Consultants The high-dose aldesleukin (HD IL-2) Select trial in patients with metastatic renal cell carcinoma (mRCC): Preliminary assessment of clinical benefit. ... |